Clinical Trial Update: Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes [NA]

View source ↗

Summary

A completed clinical trial investigated how GLP-1 signaling and liraglutide influence brain satiety and reward circuits and feeding behavior in obesity and type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Obesity, Type 2 Diabetes | NA | Status: COMPLETED